Design, synthesis, and anticonvulsant effects evaluation of nonimidazole histamine H3 receptor antagonists/inverse agonists containing triazole moiety. (1st January 2020)
- Record Type:
- Journal Article
- Title:
- Design, synthesis, and anticonvulsant effects evaluation of nonimidazole histamine H3 receptor antagonists/inverse agonists containing triazole moiety. (1st January 2020)
- Main Title:
- Design, synthesis, and anticonvulsant effects evaluation of nonimidazole histamine H3 receptor antagonists/inverse agonists containing triazole moiety
- Authors:
- Song, Mingxia
Yan, Rui
Zhang, Yanhui
Guo, Dongfu
Zhou, Naiming
Deng, XianQing - Abstract:
- Abstract: Histamine H3 receptors (H3 R) antagonists/inverse agonists are becoming a promising therapeutic approach for epilepsy. In this article, novel nonimidazole H3 R antagonists/inverse agonists have been designed and synthesised via hybriding the H3 R pharmacophore (aliphatic amine with propyloxy chain) with the 1, 2, 4-triazole moiety as anticonvulsant drugs. The majority of antagonists/inverse agonists prepared here exerted moderate to robust activities in cAMP-response element (CRE) luciferase screening assay. 1-(3-(4-(3-Phenyl-4 H -1, 2, 4-triazol-4-yl)phenoxy)propyl)piperidine (3l ) and 1-(3-(4-(3-(4-chlorophenyl)-4 H -1, 2, 4-triazol-4-yl)phenoxy)propyl)piperidine (3m ) displayed the highest H3 R antagonistic activities, with IC50 values of 7.81 and 5.92 nM, respectively. Meanwhile, the compounds with higher H3 R antagonistic activities exhibited protection for mice in maximal electroshock seizure (MES)-induced convulsant model. Moreover, the protection of 3m against the MES induced seizures was fully abrogated when mice were co-treated with RAMH, a CNS-penetrant H3 R agonist, which suggested that the potential therapeutic effect of 3m was through H3 R. These results indicate that the attempt to find new anticonvulsant among H3 R antagonists/inverse agonists is practicable.
- Is Part Of:
- Journal of enzyme inhibition and medicinal chemistry. Volume 35:Number 1(2020)
- Journal:
- Journal of enzyme inhibition and medicinal chemistry
- Issue:
- Volume 35:Number 1(2020)
- Issue Display:
- Volume 35, Issue 1 (2020)
- Year:
- 2020
- Volume:
- 35
- Issue:
- 1
- Issue Sort Value:
- 2020-0035-0001-0000
- Page Start:
- 1310
- Page End:
- 1321
- Publication Date:
- 2020-01-01
- Subjects:
- Epilepsy -- anticonvulsant -- H3 receptor antagonists/inverse agonists -- hybrid -- 1, 2, 4-triazole
Enzyme inhibitors -- Periodicals
Enzyme Inhibitors -- periodicals
Biochemistry -- periodicals
572.7 - Journal URLs:
- http://informahealthcare.com/loi/enz ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/14756366.2020.1774573 ↗
- Languages:
- English
- ISSNs:
- 1475-6366
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4979.465000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23574.xml